London, England, United Kingdom · Remote OK
$140k–$160k/yr
At Alamar, we are passionate about enabling our customers to make scientific discoveries that translate into clinical outcomes and benefit patients. Our team is growing quickly as we develop innovative approaches to meas…
Skills: Business Development, Strategic Partnerships, Consultative Selling, Territory Planning, CRM Utilization
London, England, United Kingdom • Remote OK
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Lead commercial activities across EMEA to build strategic partnerships with population health cohorts, biobanks, and biopharmaceutical organizations. Drive the adoption of precision proteomics platforms to achieve revenue targets and expand the company's market footprint.
Requires a Bachelor's degree in Life Sciences (MBA preferred) and 8-10 years of business development experience in life sciences or healthcare technology. Must possess deep scientific acumen in proteomics and the ability to manage complex sales cycles across diverse international markets.
At Alamar, we are passionate about enabling our customers to make scientific discoveries that translate into clinical outcomes and benefit patients. Our team is growing quickly as we develop innovative approaches to measure critical protein biomarkers from liquid samples that can enable the earliest possible detection of disease. We believe the next frontier in biology is enabled by measuring proteins at higher sensitivity in highly multiplexed assays at the push of a button, which is something only Alamar can do. As we build our team, we seek collaborative, driven, intellectually curious people committed to solving complex challenges. Our culture rewards accountability and cross functional teamwork because we believe this enables the kind of breakthrough thinking that will accelerate our mission.
We are seeking a dynamic, collaborative, and results-driven sales professional to join our growing team. Reporting to the Vice President Business Development Global Population Health, you will play a pivotal role in shaping and executing Alamar’s commercial strategy within EMEA while contributing to our global expansion of population health cohorts.
In this field-based role, you will:
This is an opportunity to join a company transforming biomarker-driven healthcare and make a lasting impact on scientific innovation and patient outcomes.
Primary responsibilities include:
Requirements include:
The base salary range for this full-time position is £140,000 - £160,000 + bonus + equity + benefits. Our salary ranges are determined by work location, job-related skills, experience, and relevant education or training. The ranges displayed on each job posting reflect the minimum and maximum target for new hire salaries but are subject to change if the leveling of the role is adjusted. Your recruiter can share more about the specific salary range during the hiring process.
Please Note - We participate in E-Verify to confirm authorization to work in the United States.
Powering Precision Proteomics with unrivaled sensitivity and simplicity
Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels. Our proprietary NULISA™ Chemistry utilizes a novel sequential capture and release method that significantly reduces background signal and increases the sensitivity and dynamic range compared with standard approaches and allows both qPCR and NGS readouts. The NULISAseq Inflammation Panel contains 200+ important markers related to immune and inflammatory diseases and will run on our ARGO™ System. This innovative platform allows for a fully automated workflow with less than 30 minutes hands on time from sample to data.
Offices: 47071 Bayside Pkwy, Fremont, California 94538, US
Powering Precision Proteomics with unrivaled sensitivity and simplicity
Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels. Our proprietary NULISA™ Chemistry utilizes a novel sequential capture and release method that significantly reduces background signal and increases the sensitivity and dynamic range compared with standard approaches and allows both qPCR and NGS readouts. The NULISAseq Inflammation Panel contains 200+ important markers related to immune and inflammatory diseases and will run on our ARGO™ System. This innovative platform allows for a fully automated workflow with less than 30 minutes hands on time from sample to data.
Offices: 47071 Bayside Pkwy, Fremont, California 94538, US
